374 related articles for article (PubMed ID: 16407065)
1. A second FMN binding site in yeast NADPH-cytochrome P450 reductase suggests a mechanism of electron transfer by diflavin reductases.
Lamb DC; Kim Y; Yermalitskaya LV; Yermalitsky VN; Lepesheva GI; Kelly SL; Waterman MR; Podust LM
Structure; 2006 Jan; 14(1):51-61. PubMed ID: 16407065
[TBL] [Abstract][Full Text] [Related]
2. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
Roitel O; Scrutton NS; Munro AW
Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
[TBL] [Abstract][Full Text] [Related]
3. Equilibrium and transient state spectrophotometric studies of the mechanism of reduction of the flavoprotein domain of P450BM-3.
Sevrioukova I; Shaffer C; Ballou DP; Peterson JA
Biochemistry; 1996 Jun; 35(22):7058-68. PubMed ID: 8679531
[TBL] [Abstract][Full Text] [Related]
4. Four crystal structures of the 60 kDa flavoprotein monomer of the sulfite reductase indicate a disordered flavodoxin-like module.
Gruez A; Pignol D; Zeghouf M; Covès J; Fontecave M; Ferrer JL; Fontecilla-Camps JC
J Mol Biol; 2000 May; 299(1):199-212. PubMed ID: 10860732
[TBL] [Abstract][Full Text] [Related]
5. Interflavin one-electron transfer in the inducible nitric oxide synthase reductase domain and NADPH-cytochrome P450 reductase.
Yamamoto K; Kimura S; Shiro Y; Iyanagi T
Arch Biochem Biophys; 2005 Aug; 440(1):65-78. PubMed ID: 16009330
[TBL] [Abstract][Full Text] [Related]
6. The flavoprotein domain of P450BM-3: expression, purification, and properties of the flavin adenine dinucleotide- and flavin mononucleotide-binding subdomains.
Sevrioukova I; Truan G; Peterson JA
Biochemistry; 1996 Jun; 35(23):7528-35. PubMed ID: 8652532
[TBL] [Abstract][Full Text] [Related]
7. Effect of the Insertion of a Glycine Residue into the Loop Spanning Residues 536-541 on the Semiquinone State and Redox Properties of the Flavin Mononucleotide-Binding Domain of Flavocytochrome P450BM-3 from Bacillus megaterium.
Chen HC; Swenson RP
Biochemistry; 2008 Dec; 47(52):13788-99. PubMed ID: 19055322
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of a 5'-deazaFAD T491V NADPH-cytochrome P450 reductase.
Zhang H; Gruenke L; Saribas AS; Im SC; Shen AL; Kasper CB; Waskell L
Biochemistry; 2003 Jun; 42(22):6804-13. PubMed ID: 12779335
[TBL] [Abstract][Full Text] [Related]
9. Functional interactions in cytochrome P450BM3: flavin semiquinone intermediates, role of NADP(H), and mechanism of electron transfer by the flavoprotein domain.
Murataliev MB; Klein M; Fulco A; Feyereisen R
Biochemistry; 1997 Jul; 36(27):8401-12. PubMed ID: 9204888
[TBL] [Abstract][Full Text] [Related]
10. Obligatory intermolecular electron-transfer from FAD to FMN in dimeric P450BM-3.
Kitazume T; Haines DC; Estabrook RW; Chen B; Peterson JA
Biochemistry; 2007 Oct; 46(42):11892-901. PubMed ID: 17902705
[TBL] [Abstract][Full Text] [Related]
11. Potentiometric and further kinetic characterization of the flavin-binding domain of Saccharomyces cerevisiae flavocytochrome b2. Inhibition by anions binding in the active site.
Cénas N; Lê KH; Terrier M; Lederer F
Biochemistry; 2007 Apr; 46(15):4661-70. PubMed ID: 17373777
[TBL] [Abstract][Full Text] [Related]
12. The closed and compact domain organization of the 70-kDa human cytochrome P450 reductase in its oxidized state as revealed by NMR.
Vincent B; Morellet N; Fatemi F; Aigrain L; Truan G; Guittet E; Lescop E
J Mol Biol; 2012 Jul; 420(4-5):296-309. PubMed ID: 22543241
[TBL] [Abstract][Full Text] [Related]
13. Proximal FAD histidine residue influences interflavin electron transfer in cytochrome P450 reductase and methionine synthase reductase.
Meints CE; Parke SM; Wolthers KR
Arch Biochem Biophys; 2014 Apr; 547():18-26. PubMed ID: 24589657
[TBL] [Abstract][Full Text] [Related]
14. Quantitation of FAD-dependent cytochrome P450 reductase activity by photoreduction.
Hodgson AV; Strobel HW
Anal Biochem; 1996 Dec; 243(1):154-7. PubMed ID: 8954538
[TBL] [Abstract][Full Text] [Related]
15. Determination of the redox properties of human NADPH-cytochrome P450 reductase.
Munro AW; Noble MA; Robledo L; Daff SN; Chapman SK
Biochemistry; 2001 Feb; 40(7):1956-63. PubMed ID: 11329262
[TBL] [Abstract][Full Text] [Related]
16. Crystallization and preliminary X-ray diffraction studies of human cytochrome P450 reductase.
Zhao Q; Smith G; Modi S; Paine M; Wolf RC; Tew D; Lian LY; Primrose WU; Roberts GC; Driessen HP
J Struct Biol; 1996; 116(2):320-5. PubMed ID: 8812989
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the FAD binding domain of cytochrome P450 reductase.
Hodgson AV; Strobel HW
Arch Biochem Biophys; 1996 Jan; 325(1):99-106. PubMed ID: 8554349
[TBL] [Abstract][Full Text] [Related]
18. Relaxation kinetics of cytochrome P450 reductase: internal electron transfer is limited by conformational change and regulated by coenzyme binding.
Gutierrez A; Paine M; Wolf CR; Scrutton NS; Roberts GC
Biochemistry; 2002 Apr; 41(14):4626-37. PubMed ID: 11926825
[TBL] [Abstract][Full Text] [Related]
19. Molecular dissection of human methionine synthase reductase: determination of the flavin redox potentials in full-length enzyme and isolated flavin-binding domains.
Wolthers KR; Basran J; Munro AW; Scrutton NS
Biochemistry; 2003 Apr; 42(13):3911-20. PubMed ID: 12667082
[TBL] [Abstract][Full Text] [Related]
20. An appraisal of multiple NADPH binding-site models proposed for cytochrome P450 reductase, NO synthase, and related diflavin reductase systems.
Daff S
Biochemistry; 2004 Apr; 43(13):3929-32. PubMed ID: 15049700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
